REDWOOD CITY, Calif.--(BUSINESS WIRE)--Sep. 13, 2012--
Codexis, Inc. (NASDAQ: CDXS), a developer of cost-advantaged processes
for the production of biofuels, bio-based chemicals, and
pharmaceuticals, today announced participation at the following upcoming
World Biofuels Markets Brazil
Date: Tuesday, September 18
4:20 p.m. BRT
Location: Grand Hyatt Sao Paulo in Sao Paulo, Brazil
David Anton, Senior Vice President, Bioindustrials
Credit Suisse 3rd Annual Small & Mid Cap Conference
Thursday, September 20
Time: 8:00 a.m. EDT
Location: New York
Palace Hotel in New York, NY
Speaker: John Nicols, President and
Chief Executive Officer
About Codexis, Inc.
Codexis, Inc. is a developer of cost-advantaged processes for the
production of biofuels, bio-based chemicals and pharmaceuticals.
Codexis’ product lines include CodeXyme™ cellulase enzymes and CodeXol™
detergent alcohol. Partners and customers include global leaders such as
Merck, Pfizer and Teva. For more information, see www.codexis.com.
Source: Codexis, Inc.
Paul Cox, 212-362-1200